Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study

BACKGROUND: A key barrier to cervical cancer elimination in China is low human papillomavirus (HPV) vaccine uptake, which is limited by supply constraints, high prices, and restriction to two/three-dose schedule. We explored optimal vaccination strategies for maximizing health and economic benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Tingting, Zhao, Xuelian, Hu, Shangying, Gao, Meng, Liu, Yang, Zhang, Yong, Qiao, Youlin, Jit, Mark, Zhao, Fanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813696/
https://www.ncbi.nlm.nih.gov/pubmed/36618898
http://dx.doi.org/10.1016/j.eclinm.2022.101789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813696/
https://www.ncbi.nlm.nih.gov/pubmed/36618898
http://dx.doi.org/10.1016/j.eclinm.2022.101789

Ejemplares similares